Blog

Recap of Recent Webinar: Medications for Stimulant Use Disorder
In case you missed it…
CBAM’s Dr. Shoptaw quoted in New York Times
Substance abuse treatment helps reduce reported methamphetamine use among men who have sex with men
UCLA/USC Panel on Methadone
Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial

About

CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.